Quick Takeaways
- Ikarian Capital, LLC filed SCHEDULE 13G/A for Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS).
- Disclosed ownership: 6.1%.
- Date of event: 30 Sep 2025.
Ikarian Capital, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS)
- Filing Manager
- Ikarian Capital, LLC
- Reporting Manager
- Ikarian Capital, LLC
- Symbol
- PTHS
- Shares outstanding
- 3,055,869 shares
- Disclosed Ownership
- 186,408 shares
- Ownership
- 6.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 18:33:17 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Ikarian Capital, LLC disclosed 6.1% ownership in Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 18:33.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 6.1% | 186,408 | 0 | 186,408 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager | |
| Neil Shahrestani | 6.1% | 186,408 | 0 | 186,408 | /s/ Neil Shahrestani | Neil Shahrestani |